Liver prenylated methylated protein methyl esterase is the same enzyme as Sus scrofa carboxylesterase

Journal of Biochemical and Molecular Toxicology

Volumn 22, Issue 1, 2008, Pages 51-62

  Oboh, Onovughode T ^a   Lamango, Nazarius S ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Carboxymethyl esterase; Ebelactone; Hydrolase; Organophosphates; Prenylated proteins; Prenylation

Indexed keywords

BENZOYLGLYCYLFARNESYLCYSTEINE METHYL ESTER; BENZYLSULFONYL FLUORIDE; CARBOXYLESTERASE; COCAINE; EBELACTONE A; EBELACTONE B; ESTERASE; HYDROCINNAMOYLFARNESYLCYSTEINE METHYL ESTER; KETONE DERIVATIVE; MECYSTEINE; ORGANOPHOSPHATE; PRENYLATED METHYLATED PROTEIN METHYL ESTERASE; SERINE DEHYDRATASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; ENDOPLASMIC RETICULUM; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME SUBSTRATE COMPLEX; HYDROLYSIS; HYDROPHOBICITY; LIVER HOMOGENATE; MASS; MICHAELIS CONSTANT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRENYLATION; PROTEIN METHYLATION; PROTEOMICS; SUPERNATANT; SWINE;

MAMMALIA; SUS; SUS SCROFA;

EID: 40549144311     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20214     Document Type: Article

References (52)

1. 1 Nalivaeva NN, Turner AJ. Post‐translational modifications of proteins: Acetylcholinesterase as a model system. Proteomics 2001 ; 1: 735–747.
2. 2 Ma YT, Shi YQ, Lim YH, McGrail SH, Ware JA, Rando RR. Mechanistic studies on human platelet isoprenylated protein methyltransferase: Farnesylcysteine analogs block platelet aggregation without inhibiting the methyltransferase. Biochemistry 1994 ; 33: 5414–5420.
3. 3 Perez‐Sala D, Tan EW, Canada FJ, Rando RR. Methylation and demethylation reactions of guanine nucleotide‐binding proteins of retinal rod outer segments. Proc Natl Acad Sci USA. 1991 ; 88: 3043–3046.
4. 4 Myung CS, Yasuda H, Liu WW, Harden TK, Garrison JC. Role of isoprenoid lipids on the heterotrimeric G protein gamma subunit in determining effector activation. J Biol Chem 1999 ; 274: 16595–16603.
5. 5 Dietrich A, Meister M, Brazil D, Camps M, Gierschik P. Stimulation of phospholipase C‐beta 2 by recombinant guanine‐nucleotide‐binding protein beta gamma dimers produced in a baculovirus/insect cell expression system. Requirement of gamma‐subunit isoprenylation for stimulation of phospholipase C. Eur J Biochem 1994 ; 219: 171–178.
6. 6 Gosser YQ, Nomanbhoy TK, Aghazadeh B, Manor D, Combs C, Cerione RA, Rosen MK. C‐terminal binding domain of Rho GDP‐dissociation inhibitor directs N‐terminal inhibitory peptide to GTPases. Nature 1997 ; 387: 814–819.
7. 7 Lamango NS, Charlton CG. Farnesyl‐L‐cysteine analogs block SAM‐induced Parkinson's disease‐like symptoms in rats. Pharmacol Biochem Behav 2000 ; 66: 841–849.
8. 8 Lamango NS, Ayuk‐Takem LT, Nesby R, Zhao WQ, Charlton CG. Inhibition mechanism of S‐adenosyl methionine‐induced movement deficits by prenylcysteine analogs Pharmacol Biochem Behav 2003 ; 76: 433–442.
9. 9 Scheer A, Gierschik P. S‐prenylated cysteine analogues inhibit receptor‐mediated G protein activation in native human granulocyte and reconstituted bovine retinal rod outer segment membranes. Biochemistry 1995 ; 34: 4952–4961.
10. 10 Lamango NS. Liver prenylated methylated protein methyl esterase is an organophosphate‐sensitive enzyme. J Biochem Mol Toxicol 2005 ; 19: 347–357.
11. 11 Glynn P. Neuropathy target esterase and phospholipid deacylation. Biochim Biophys Acta 2005 ; 1736: 87–93.
12. 12 Costa LG. Current issues in organophosphate toxicology. Clin Chim Acta 2006 ; 366: 1–13.
13. 13 Kwong TC. Organophosphate pesticides: Biochemistry and clinical toxicology. Ther Drug Monit 2002 ; 24: 144–149.
14. 14 Tan EW, Rando RR. Identification of an isoprenylated cysteine methyl ester hydrolase activity in bovine rod outer segment membranes. Biochemistry 1992 ; 31: 5572–5578.
15. 15 Kokotos G, Kotsovolou S, Constantinou‐Kokotou V, Wu G, Olivecrona G. Inhibition of lipoprotein lipase by alkanesulfonyl fluorides. Bioorg Med Chem Lett 2000 ; 10: 2803–2806.
16. 16 Pasquato A, Pullikotil P, Asselin MC, Vacatello M, Paolillo L, Ghezzo F, Basso F, Di Bello C, Dettin M, Seidah NG. The proprotein convertase SKI‐1/S1P. In vitro analysis of Lassa virus glycoprotein‐derived substrates and ex vivo validation of irreversible peptide inhibitors J Biol Chem 2006 ; 281: 23471–23481.
17. 17 Ma YT, Gilbert BA, Rando RR. Farnesylcysteine analogs to probe role of prenylated protein methyltransferase. Methods Enzymol 1995 ; 250: 226–234.
18. 18 Uttamsingh V, Keller DA, Anders MW. Acylase I‐catalyzed deacetylation of N‐acetyl‐L‐cysteine and S‐alkyl‐ N ‐acetyl‐L‐cysteines. Chem Res Toxicol 1998 ; 11: 800–809.
19. 19 Minton NA, Murray VS. A review of organophosphate poisoning. Med Toxicol Adverse Drug Exp 1998 ; 3: 350–375.
20. 20 Bergo MO, Leung GK, Ambroziak P, Otto JC, Casey PJ, Gomes AQ, Seabra MC, Young SG. Isoprenylcysteine carboxyl methyltransferase deficiency in mice. J Biol Chem 2001 ; 276: 5841–5845.
21. 21 Sanghani SP, Davis WI, Dumaual NG, Mahrenholz A, Bosron WF. Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate. Eur J Biochem 2002 ; 269: 4387–4398.
22. 22 Furihata T, Hosokawa M, Nakata F, Satoh T, Chiba K. Purification, molecular cloning, and functional expression of inducible liver acylcarnitine hydrolase in C57BL/6 mouse, belonging to the carboxylesterase multigene family. Arch Biochem Biophys 2003 ; 416: 101–109.
23. 23 David L, Guo XJ, Villard C, Moulin A, Puigserver A. Purification and molecular cloning of porcine intestinal glycerol‐ester hydrolase–evidence for its identity with carboxylesterase. Eur J Biochem 1998 ; 257: 142–148.
24. 24 Redinbo MR, Bencharit S, Potter PM. Human carboxylesterase 1: From drug metabolism to drug discovery. Biochem Soc Trans 2003 ; 31: 620–624.
25. 25 Fleming CD, Bencharit S, Edwards CC, Hyatt JL, Tsurkan L, Bai F, Fraga C, Morton CL, Howard‐Williams EL, Potter PM, Redinbo MR. Structural insights into drug processing by human carboxylesterase 1: Tamoxifen, mevastatin, and inhibition by benzil. J Mol Biol 2005 ; 352: 165–177.
26. 26 Bencharit S, Morton CL, Xue Y, Potter PM, Redinbo MR. Structural basis of heroin and cocaine metabolism by a promiscuous human drug‐processing enzyme. Nat Struct Biol 2003 ; 10: 349–356.
27. 27 Bencharit S, Morton CL, Hyatt JL, Kuhn P, Danks MK, Potter PM, Redinbo MR. Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: From binding promiscuity to selective inhibition. Chem Biol 2003 ; 10: 341–349.
28. 28 Potter PM, Wolverton JS, Morton CL, Wierdl M, Danks MK. Cellular localization domains of a rabbit and a human carboxylesterase: Influence on irinotecan (CPT‐11) metabolism by the rabbit enzyme. Cancer Res 1998 ; 58: 3627–3632.
29. 29 Romano JD, Schmidt WK, Michaelis S. The Saccharomyces cerevisiae prenylcysteine carboxyl methyltransferase Ste14p is in the endoplasmic reticulum membrane. Mol Biol Cell 1998 ; 9: 2231–2247.
30. 30 Roskoski R Jr. Protein prenylation: A pivotal posttranslational process. Biochem Biophys Res Commun 2003 ; 303: 1–7.
31. 31 Arima H, Sobue K, So M, Morishima T, Ando H, Katsuya H. Transient and reversible parkinsonism after acute organophosphate poisoning. J Toxicol Clin Toxicol 2003 ; 41: 67–70.
32. 32 Kventsel I, Berkovitch M, Reiss A, Bulkowstein M, Kozer E. Scopolamine treatment for severe extra‐pyramidal signs following organophosphate (chlorpyrifos) ingestion. Clin Toxicol (Phila) 2005 ; 43: 877–879.
33. 33 Shahar E, Bentur Y, Bar‐Joseph G, Cahana A, Hershman E. Extrapyramidal parkinsonism complicating acute organophosphate insecticide poisoning. Pediatr Neurol 2005 ; 33: 378–382.
34. 34 Bhatt MH, Elias MA, Mankodi AK. Acute and reversible parkinsonism due to organophosphate pesticide intoxication: Five cases. Neurology 1999 ; 52: 1467–1471.
35. 35 Muller‐Vahl KR, Kolbe H, Dengler R. Transient severe parkinsonism after acute organophosphate poisoning. J Neurol Neurosurg Psychiatry 1999 ; 66: 253–254.
36. 36 Davis KL, Yesavage JA, Berger PA Single case study. Possible organophosphate‐induced parkinsonism. J Nerv Ment Dis 1978 ; 166: 222–225.
37. 37 Hsieh BH, Deng JF, Ger J, Tsai WJ. Acetylcholinesterase inhibition and the extrapyramidal syndrome: A review of the neurotoxicity of organophosphate. Neurotoxicology 2001 ; 22: 423–427.
38. 38 Lamango NS, Nesby RA, Charlton CG. Quantification of S‐adenosylmethionine‐induced tremors: A possible tremor model for Parkinson's disease. Pharmacol Biochem Behav 2000 ; 65: 523–529.
39. 39 Ascherio A, Chen H, Weisskopf MG, O'Reilly E, McCullough ML, Calle EE, Schwarzschild MA, Thun MJ. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 2006 ; 60: 197–203.
40. 40 Glynn P. A mechanism for organophosphate‐induced delayed neuropathy. Toxicol Lett 2006 ; 162: 94–97.
41. 41 Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, Labaer J, Rochet JC, Bonini NM, Lindquist S. Alpha‐synuclein blocks ER‐Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006 ; 313: 324–328.
42. 42 Martinez O, Goud B. Rab proteins. Biochim Biophys Acta 1998 ; 1404: 101–112.
43. 43 Leung KF, Baron R, Ali BR, Magee AI, Seabra MC. Rab GTPases containing a CAAX motif are processed post‐geranylgeranylation by proteolysis and methylation. J Biol Chem 2007 ; 282: 1487–1497.
44. 44 Munger JS, Shi GP, Mark EA, Chin DT, Gerard C, Chapman HA. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem 1991 ; 266: 18832–18838.
45. 45 Becker A, Bottcher A, Lackner KJ, Fehringer P, Notka F, Aslanidis C, Schmitz G. Purification, cloning, and expression of a human enzyme with acyl coenzyme A: Cholesterol acyltransferase activity, which is identical to liver carboxylesterase. Arterioscler Thromb 1994 ; 14: 1346–1355.
46. 46 Ghosh S. Cholesteryl ester hydrolase in human monocyte/macrophage: Cloning, sequencing, and expression of full‐length cDNA. Physiol Genomics 2000 ; 2: 1–8.
47. 47 Potter PM, Pawlik CA, Morton CL, Naeve CW, Danks MK. Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT‐11). Cancer Res 1998 ; 58: 2646–2651.
48. 48 Robbi M., Beaufay H, Octave JN. Nucleotide sequence of cDNA coding for rat liver pI 6.1 esterase (ES‐10), a carboxylesterase located in the lumen of the endoplasmic reticulum. Biochem J 1990 ; 269: 451–458.
49. 49 Sone T, Isobe M, Takabatake E, Wang CY. Cloning and sequence analysis of a hamster liver cDNA encoding a novel putative carboxylesterase. Biochim Biophys Acta 1994 ; 1207: 138–142.
50. 50 Dolinsky VW, Sipione S, Lehner R, Vance DE. The cloning and expression of a murine triacylglycerol hydrolase cDNA and the structure of its corresponding gene. Biochim Biophys Acta 2001 ; 1532: 162–172.
51. 51 Mori M, Hosokawa M, Ogasawara Y, Tsukada E, Chiba K. cDNA cloning, characterization and stable expression of novel human brain carboxylesterase. FEBS Lett 1999 ; 458: 17–22.
52. 52 Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ, Marra MA. Generation and initial analysis of more than 15000 full‐length human and mouse cDNA sequences, Proc Natl Acad Sci USA 2002 ; 99: 16899–16903.